Ovarian cancer differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 107: | Line 107: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women in reproductive age (15 -45 y/o) | * Women in reproductive age (15 -45 y/o) | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* [[Iron deficiency anemia]] | * [[Iron deficiency anemia]] | ||
Line 135: | Line 135: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* 10-30 y/o | * 10-30 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of HCG and LDH | * High level of HCG and LDH | ||
Line 162: | Line 162: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* in the second to third decade of life | * in the second to third decade of life | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of HCG and LDH | * High level of HCG and LDH | ||
Line 186: | Line 186: | ||
* Young children | * Young children | ||
* Male infants | * Male infants | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High levels of AFP | * High levels of AFP | ||
Line 214: | Line 214: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Pulling sensation in the groin | * Pulling sensation in the groin | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High levels of CA-125 | * High levels of CA-125 | ||
Line 238: | Line 238: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >50 y/o | * >50 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Postmenopausal bleeding | * Postmenopausal bleeding | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of estrogen | * High level of estrogen | ||
Line 266: | Line 266: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* 50-60 y/o | * 50-60 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Postmenopausal bleeding | * Postmenopausal bleeding | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of estrogen and progestron | * High level of estrogen and progestron | ||
Line 290: | Line 290: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* 15 to 35 y/o | * 15 to 35 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | s| style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Elevated serum testosterone level | * Elevated serum testosterone level | ||
Line 317: | Line 317: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >55 y/o | * >55 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
:* In US we may see hypoechoic solid mass and calcification | :* In US we may see hypoechoic solid mass and calcification | ||
Line 340: | Line 340: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >55 y/o | * >55 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Based on underlying malignancy | Based on underlying malignancy | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
Based on underlying malignancy | Based on underlying malignancy | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In case of metastatic GI cancers we may see iron deficiency anemia | * In case of metastatic GI cancers we may see iron deficiency anemia | ||
Line 368: | Line 368: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Young women (15-30 y/o | * Young women (15-30 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High levels of inflammatory markers | * High levels of inflammatory markers | ||
Line 393: | Line 393: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women in reproductive age (15 -45 y/o) | * Women in reproductive age (15 -45 y/o) | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of BhCG | * High level of BhCG | ||
Line 416: | Line 416: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* NA | * NA | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In US we may see tubal longitudinal folds thickening (cogwheel appearance) | * In US we may see tubal longitudinal folds thickening (cogwheel appearance) | ||
Line 440: | Line 440: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women of reproductive age | * Women of reproductive age | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Leukocytosis | * Leukocytosis | ||
Line 462: | Line 462: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >60 y/o | * >60 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High levels of CA125 | * High levels of CA125 | ||
Line 493: | Line 493: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women of reproductive age | * Women of reproductive age | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | – | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In chronic cases, we may see mild anemia | * In chronic cases, we may see mild anemia | ||
Line 516: | Line 516: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women in reproductive age (15 -45 y/o) | * Women in reproductive age (15 -45 y/o) | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of B-hCG | * High level of B-hCG | ||
Line 546: | Line 546: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* >55 y/o | * >55 y/o | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" | + | | style="background: #F5F5F5; padding: 5px; text-align: center;" | + | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | +/– | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* In some cases we may see elevated levels of CA 125 lactate dehydrogenase | * In some cases we may see elevated levels of CA 125 lactate dehydrogenase | ||
Line 569: | Line 569: | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* Women in reproductive age (15 -45 y/o) | * Women in reproductive age (15 -45 y/o) | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" | +/− | | style="background: #F5F5F5; padding: 5px; text-align: center;" | +/− | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" |– | | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | ||
| style="background: #F5F5F5; padding: 5px;" | | | style="background: #F5F5F5; padding: 5px;" | | ||
* High level of BhCG | * High level of BhCG |
Revision as of 16:05, 7 February 2019
Ovarian cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Ovarian cancer differential diagnosis On the Web |
American Roentgen Ray Society Images of Ovarian cancer differential diagnosis |
Risk calculators and risk factors for Ovarian cancer differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.
Overview
Differentiating [Disease name] from other Diseases
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age of onset | Symptoms | Physical examination | ||||||||||||
Lab Findings | Imaging | Immunohistopathology | ||||||||||||
pelvic/abdominal pain or pressure | vaginal bleeding/discharge | GI dysturbance | Pleural effusion | Fever | Tenderness | CT scan/US | MRI | |||||||
Gynecologic | ||||||||||||||
Ovarian | Follicular cysts | – |
| |||||||||||
Theca lutein cysts | – |
|
| |||||||||||
Serous cystadenoma/carcinoma |
|
– |
|
| ||||||||||
Mucinous cystadenoma/carcinoma |
|
– |
| |||||||||||
Endometrioma |
|
+ | + | +/– | – | – | + |
|
|
|
|
|
| |
Teratoma |
|
+/– | – | – | – | – | +/– |
|
|
|
|
|
| |
Dysgerminoma |
|
+ | +/– | – | – | – | +/– |
|
|
|
|
|
| |
Yolk sac tumor |
|
+ | – | – | – | – | + |
|
|
|
|
|
| |
Fibroma |
|
|
– | – | +/– | – | +/– |
|
|
|
|
|
| |
Thecoma |
|
+/– |
|
– | – | – | – |
|
|
|
|
|
| |
Granulosa cell tumor |
|
+ |
|
+/– | – | – | – |
|
|
|
|
|
| |
Sertoli-leydig cell tumor |
|
+/– | – | – | – | style="background: #F5F5F5; padding: 5px; text-align: center;" |– | – |
|
|
|
|
|
| |
Brenner tumor |
|
+/– | – | – | – | – | – | – |
|
|
|
|
| |
Krukenberg tumor |
|
+/– | – | +/–
Based on underlying malignancy |
+/–
Based on underlying malignancy |
– | – |
|
|
|
|
Imaging/biopsy |
| |
Tubal | tubo-ovarian abscess |
|
+ | + | – | – | + | + |
|
|
|
|
|
|
Ectopic pregnancy |
|
+ | + | +/– | – | – | + |
|
|
|
|
|
| |
Hydrosalpinx |
|
+ | – | – | – | – | +/– | – |
|
|
|
|
| |
Salpingitis |
|
+ | + | – | – | + | + |
|
|
|
|
|
| |
Fallopian tube carcinoma |
|
+ | + | + | + | – | +/– |
|
|
|
|
|
| |
Uterine | Leiomyoma |
|
+ | + | – | – | – | +/– |
|
|
|
|
|
|
Choriocarcinoma |
|
+ | + | +/– | – | – | + |
|
|
|
|
|
| |
Leiomyosarcoma |
|
+ | + | – | – | – | +/– |
|
|
|
|
|
| |
Pregnancy |
|
+/− | +/− | +/− | – | – | – |
|
|
|
|
|
| |
Non-gynecologic | ||||||||||||||
GIT | Appendiceal abscess |
|
+ | – | + | + | +/– | + |
|
|
|
|
|
|
Appendiceal neoplasm[1] |
|
+ | – | + | + | – | +/– |
|
|
|
|
|
| |
Diverticular abscess |
|
+ | – | + | + | +/– | + |
|
|
|
|
|
| |
Colorectal cancer |
|
+ | – | + | – | – | +/– |
|
|
|
|
|
| |
Renal | Pelvic kidney |
|
−/+
In case of sever hydronephrosis or renal stone we may have pelvic pain |
– | − | − | − | − | − |
|
|
|
|
|
Bladder cancer |
|
+ | – | – | – | – | – |
|
|
|
|
|
| |
Others | Retroperitoneal sarcoma[2] |
|
+ | – | + | − | − | − |
|
|
|
|
|
|
check sites of cancer that may metastasize to the ovaries (eg, stomach, colorectal, breast)
check rectum, liver, spleen, lungs, inguinal or supraclavicular lymph nodes for ovary metastase
- Bladder tumour–associated antigen (BTA)
- Nuclear matrix proteins (NMP)
- Mucin and carcinoembryonic antigen (CEA)
References
- ↑ Chapter 5: Tumours of the Appendix - IARC. https://www.iarc.fr/en/publications/pdfs-online/pat-gen/bb2/bb2-chap5.pdf Accessed on January 15, 2019
- ↑ Storm FK, Mahvi DM (July 1991). "Diagnosis and management of retroperitoneal soft-tissue sarcoma". Ann. Surg. 214 (1): 2–10. PMC 1358407. PMID 2064467.